A comparison of acute treatment regimens for migraine in the emergency department

Pediatrics

Volumn 135, Issue 2, 2015, Pages 232-238

  Bachur, Richard G ^a   Monuteaux, Michael C ^a   Neuman, Mark I ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; ONDANSETRON; PROCHLORPERAZINE; TRIPTAN DERIVATIVE; TRYPTAMINE DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD HEALTH CARE; COMPARATIVE EFFECTIVENESS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MIGRAINE; MONOTHERAPY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; COMPARATIVE STUDY; DRUG COMBINATION; EMERGENCY HEALTH SERVICE; MIGRAINE DISORDERS; RECURRENT DISEASE; RISK;

ADOLESCENT; ANALGESICS; ANALGESICS, OPIOID; CHILD; COMPARATIVE EFFECTIVENESS RESEARCH; DIPHENHYDRAMINE; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; METOCLOPRAMIDE; MIGRAINE DISORDERS; ODDS RATIO; ONDANSETRON; PATIENT READMISSION; PROCHLORPERAZINE; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TRYPTAMINES;

EID: 84922598433     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-2432     Document Type: Article

References (29)

1. Lewis DW. Pediatric migraine. Neurol Clin. 2009;27(2):481-501
2. Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0. Cephalalgia. 2004;24(2):120-127
3. Ferracini GN, Dach F, Speciali JG. Quality of life and health-related disability in children with migraine. Headache. 2014; 54(2):325-334
4. Gelfand AA, Goadsby PJ. Treatment of pediatric migraine in the emergency room. Pediatr Neurol. 2012;47(4):233-241
5. Richer LP, Laycock K, Millar K, et al; Pediatric Emergency Research Canada Emergency Department Migraine Group. Treatment of children with migraine in emergency departments: national practice variation study. Pediatrics. 2010; 126(1). Available at: www.pediatrics.org/cgi/content/full/126/1/e150
6. Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med. 2012; 30(3):456-463
7. Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004; 43(2):256-262
8. Legault G, Eisman H, Shevell MI. Treatment of pediatric status migrainosus: can we prevent the "bounce back"? J Child Neurol. 2011; 26(8):949-955
9. Richer L, Graham L, Klassen T, Rowe B. Emergency department management of acute migraine in children in Canada: a practice variation study. Headache. 2007;47(5):703-710
10. Decourcey DD, Steil GM, Wypij D, Agus MS. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality. Pediatric Crit Care Med. 2013;14(7): 694-700
11. Williams DJ, Hall M, Shah SS, et al. Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia. Pediatrics. 2013;132(5). Available at: www.pediatrics.org/cgi/content/full/132/5/e1141
12. Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD. Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics. 2001;107(6). Available at: www.pediatrics.org/cgi/content/full/107/6/e99
13. Alessandrini EA, Alpern ER, Chamberlain JM, et al. Developing a diagnosis-based severity classification system for use in emergency medical services for children. Acad Emerg Med. 2012;19(1): 70-78
14. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S; American Academy of Neurology Quality Standards Subcommittee; Practice Committee of the Child Neurology Society. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12): 2215-2224
15. Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008;24(5): 321-330
16. Kabbouche MA, Vockell AL, LeCates SL, Powers SW, Hershey AD. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107(4). Available at: www.pediatrics.org/cgi/content/full/107/4/e62
17. Sun H, Bastings E, Temeck J, et al. Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents. JAMA Pediatr. 2013;167(3): 243-249
18. Leung S, Bulloch B, Young C, Yonker M, Hostetler M. Effectiveness of standardized combination therapy for migraine treatment in the pediatric emergency department. Headache. 2013; 53(3):491-497
19. Friedman BW, West J, Vinson DR, Minen MT, Restivo A, Gallagher EJ. Current management of migraine in US emergency departments: An analysis of the National Hospital Ambulatory Medical Care Survey [published online ahead of print June 19, 2014]. Cephalalgia
20. Coppola M, Yealy DM, Leibold RA. Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995;26(5): 541-546
21. Vinson DR, Drotts DL. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Ann Emerg Med. 2001; 37(2):125-131
22. Trottier ED, Bailey B, Dauphin-Pierre S, Gravel J. Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department. J Emerg Med. 2010;39(2):166-173
23. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48(1): 103-107
24. Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine - "Act when Mild (AwM)." A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008;28(4): 383-391
25. Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003;21(3): 173-175
26. Ahonen K, Hämäläinen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology. 2006;67(7): 1135-1140
27. Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012; 129(6). Available at: www.pediatrics.org/cgi/content/full/129/6/e1411
28. Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120(2): 390-396
29. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106(5): 989-997